Atlas FDA

EXCLUDER BIFURCATED ENDOPROSTHESIS

FDA premarket approval P020004/S197 · decided 2025-02-10

Approval details

PMA number
P020004
Supplement
S197
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
EXCLUDER BIFURCATED ENDOPROSTHESIS
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
W. L. Gore & Associates, Inc.
Date received
2025-01-16
Decision date
2025-02-10
Days to decision
25 days
Decision code
OK30
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Phonix, AZ
Statement
use of new injection molding equipment for production of the Gore Excluder AAA and Gore Excluder IBE delivery systems

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05